Sarepta Therapeutics
Venture capital · Cambridge, Massachusetts, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
3Deep-tech portfolio1 active
2Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Solid Biosciences
14Co-investorsShare a portfolio company
Portfolio · 3 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Arrowhead Pharmaceuticals | Biotech | Active | — | — |
| Solid Biosciences | Biotech | Public | Dec 9, 2022 | $109.2M |
| Entrada Therapeutics | Biotech | Public | Apr 13, 2021 | $150.9M |
Peer ranks
Portfolio size#136
Portfolio exits#103
Raises, 12 months#88
Co-investors#140
Co-investors
- RA CapitalVenture capital2 shared
- 5AM VenturesVenture capital1 shared
- Atlas VentureVenture capital1 shared
- BiogenVenture capital1 shared
- Biospring PartnersVenture capital1 shared
- Cormorant Asset ManagementVenture capital1 shared
- Foresite CapitalVenture capital1 shared
- Ionis PharmaceuticalsVenture capital1 shared
- OrbiMedVenture capital1 shared
- Perceptive AdvisorsVenture capital1 shared
Sectors
- Biotech3
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.